Indian Pharmaceutical and Life Sciences industry
Pharmaceutical players are increasingly focusing on expanding their product penetration in India due to the country’s large and growing healthcare market. Several strategies are driving this trend:
Tecnova India assists pharmaceutical companies in increasing their product penetration in India by providing strategic market insights, regulatory guidance, and support in establishing local operations. With its expertise in navigating the Indian healthcare sector, Tecnova helps businesses implement effective strategies for market entry, product launch, and expansion, ensuring successful integration and growth in this dynamic market.
India’s economy is growing faster, creating a large segment comprising middle-class people, allowing a rise in demand for Western medicines. Also, with the change in epidemiology, the need for cardiovascular medications and other chronic diseases is rising too. These factors have made India a promising market for global pharmaceutical companies.
While the top 10 companies in India contribute to 41% of the total sales, others contribute to 22% and 37%, respectively, making India rank 3rd in terms of volume and 14th in terms of value in the pharmaceutical industry.
With increased investment in healthcare infrastructure, there has been a rise in the number of multi-specialty and super-specialty hospitals. Each of them is equipped with the latest technologies and treatment procedures. Today India boasts almost 44,000 private hospitals consisting of nearly 2 million beds, 59,000 ICUs, and 29,600 ventilators. There are private hospitals, too, that come with 35,000 ICUs, 17,850 ventilators, and nearly 713986 beds.
Thanks to advanced internet tools and network systems, information about a new drug and the ways to use it penetrates the market easily.
Moreover, with the rise of the middle-class population, costly medicines are no longer burdensome as healthcare providers offer discounts and coupons. Also, the Indian middle class prefers going to private hospitals for treatment as these hospitals ensure personalized attention and quality care.
Besides, most Indian families have secured themselves with health insurance policies. Studies say that Government’s Ayushman Bharat policy is likely to benefit almost 65 crore people in the country, promising the out-of-pocket expenses to reduce to 20-30% in the coming years.
Apart from all these, India also has been an ideal market for global pharmaceutical companies to conduct several clinical trials. As per the recent study, the cost of Phase 1 trials is lower by 50%, and Phase 2 is lower by almost 60% compared to other markets.
India’s Government has consistently encouraged favorable policies to extend financial support to people reaching out for help with treatments. As a result, several consultant companies in India can legally facilitate the availability of newly approved medicines that are still unregistered. This is a big benefit for Indian patients and global pharma companies.
Market Entry strategies help provide pharma companies with a rock-solid plan to easily venture into the international markets. Here’s how market entry strategies help:
Apart from all these, companies use marketing and advertising strategies which are excellent tools that enhance product awareness. Depending on their marketing budget, these pharma companies plan short and long-term marketing activities. A thoughtful and well-planned strategy will always help in the development of a business.
The most crucial aspect of the success of any business is the expansion of sales and distribution networks. Since the pharma sector is large, it requires effective sales and distribution planning to reach out to every customer.
An attractive ground for renowned pharma organizations to run their business, India consists of some top management consulting firms, such as Tecnova Global, that help these global pharmaceutical companies with valuable marketing strategies to succeed here.
Management consulting firms in India offer excellent cost-effective solutions and ensure the strategies they provide are properly aligned with the operations of the businesses.
These management consulting firms adopted a new approach to the remote working system, where digital operations expand beyond video conferences. With more preference for virtual operations, the incorporation of no-code software, AI system, and other advanced technologies have boosted businesses globally.
India’s growing pharmaceutical industry is likely to become a world leader in this sector in the coming years. With effective manufacturing expertise, Indian pharma companies are now global leaders in the production of vaccines and several medicines. Therefore, as these areas tend to strengthen further, the pharmaceutical companies in India will partner with the global pharma giants to market their products outside the country.
Reference
https://bit.ly/3sBlRBw
https://bit.ly/3sAIVjS
https://bit.ly/3FlP5vJ
https://bit.ly/3zgLOtW
https://bit.ly/3zoIPj9
Indian Pharmaceutical and Life Sciences industry
Pharmaceutical players are increasingly focusing on expanding their product penetration in India due to the country’s large and growing healthcare market. Several strategies are driving this trend:
Tecnova India assists pharmaceutical companies in increasing their product penetration in India by providing strategic market insights, regulatory guidance, and support in establishing local operations. With its expertise in navigating the Indian healthcare sector, Tecnova helps businesses implement effective strategies for market entry, product launch, and expansion, ensuring successful integration and growth in this dynamic market.
India’s economy is growing faster, creating a large segment comprising middle-class people, allowing a rise in demand for Western medicines. Also, with the change in epidemiology, the need for cardiovascular medications and other chronic diseases is rising too. These factors have made India a promising market for global pharmaceutical companies.
While the top 10 companies in India contribute to 41% of the total sales, others contribute to 22% and 37%, respectively, making India rank 3rd in terms of volume and 14th in terms of value in the pharmaceutical industry.
With increased investment in healthcare infrastructure, there has been a rise in the number of multi-specialty and super-specialty hospitals. Each of them is equipped with the latest technologies and treatment procedures. Today India boasts almost 44,000 private hospitals consisting of nearly 2 million beds, 59,000 ICUs, and 29,600 ventilators. There are private hospitals, too, that come with 35,000 ICUs, 17,850 ventilators, and nearly 713986 beds.
Thanks to advanced internet tools and network systems, information about a new drug and the ways to use it penetrates the market easily.
Moreover, with the rise of the middle-class population, costly medicines are no longer burdensome as healthcare providers offer discounts and coupons. Also, the Indian middle class prefers going to private hospitals for treatment as these hospitals ensure personalized attention and quality care.
Besides, most Indian families have secured themselves with health insurance policies. Studies say that Government’s Ayushman Bharat policy is likely to benefit almost 65 crore people in the country, promising the out-of-pocket expenses to reduce to 20-30% in the coming years.
Apart from all these, India also has been an ideal market for global pharmaceutical companies to conduct several clinical trials. As per the recent study, the cost of Phase 1 trials is lower by 50%, and Phase 2 is lower by almost 60% compared to other markets.
India’s Government has consistently encouraged favorable policies to extend financial support to people reaching out for help with treatments. As a result, several consultant companies in India can legally facilitate the availability of newly approved medicines that are still unregistered. This is a big benefit for Indian patients and global pharma companies.
Market Entry strategies help provide pharma companies with a rock-solid plan to easily venture into the international markets. Here’s how market entry strategies help:
Apart from all these, companies use marketing and advertising strategies which are excellent tools that enhance product awareness. Depending on their marketing budget, these pharma companies plan short and long-term marketing activities. A thoughtful and well-planned strategy will always help in the development of a business.
The most crucial aspect of the success of any business is the expansion of sales and distribution networks. Since the pharma sector is large, it requires effective sales and distribution planning to reach out to every customer.
An attractive ground for renowned pharma organizations to run their business, India consists of some top management consulting firms, such as Tecnova Global, that help these global pharmaceutical companies with valuable marketing strategies to succeed here.
Management consulting firms in India offer excellent cost-effective solutions and ensure the strategies they provide are properly aligned with the operations of the businesses.
These management consulting firms adopted a new approach to the remote working system, where digital operations expand beyond video conferences. With more preference for virtual operations, the incorporation of no-code software, AI system, and other advanced technologies have boosted businesses globally.
India’s growing pharmaceutical industry is likely to become a world leader in this sector in the coming years. With effective manufacturing expertise, Indian pharma companies are now global leaders in the production of vaccines and several medicines. Therefore, as these areas tend to strengthen further, the pharmaceutical companies in India will partner with the global pharma giants to market their products outside the country.
Reference
https://bit.ly/3sBlRBw
https://bit.ly/3sAIVjS
https://bit.ly/3FlP5vJ
https://bit.ly/3zgLOtW
https://bit.ly/3zoIPj9